Latest Cd4+ T cells and antitumor Immunity Stories
In a study published in Nature Medicine, Loyola researchers report on a promising new technique that potentially could turn immune system killer T cells into more effective weapons against infections and possibly cancer.
DNA sequences from tumor cells can be used to direct the immune system to attack cancer.
In a study investigating immune response in cancer, researchers from Moffitt Cancer Center in Tampa, Fla., and the University of South Florida have found that interaction between the immune system's antigen-specific CD4 T cells and myeloid-derived suppressor cells (MDSC) - cells that play a major role in cancer-related immune suppression - dramatically change the nature of MDSC-mediated suppression.
At first it sounds like good news: The body's own immune system gets active in almost every cancer – however, not necessarily for the benefit of the patient.
Like humans, mice that live in their natural habitat encounter bacteria and other pathogens that exercise their immune system, yet the lab mice typically used in immunology studies are raised in isolation from most diseases.
A team of Melbourne scientists has discovered a new type of cell in the immune system.
Cancer typically doesn't kill someone as a result of the initial tumor but as a result of tumors at distant sites that are derived from the initial tumor.
A molecule that lies dormant until it encounters a cancer cell, then suddenly activates and rouses the bodyâ€™s immune system to fight cancer cells directly, marks the latest step in scientistsâ€™ efforts to tap the bodyâ€™s own resources to fight the disease.
Researchers at the University of Cambridge hope to revolutionise cancer therapy after discovering one of the reasons why many previous attempts to harness the immune system to treat cancerous tumours have failed.
- A political dynamiter.